Stephen Michael Kelsey - 17 Jun 2022 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
President, Research and Development
Signature
/s/ Jack Anders, as Attorney-in-fact for Stephen Michael Kelsey
Issuer symbol
RVMD
Transactions as of
17 Jun 2022
Net transactions value
-$20,323
Form type
4
Filing time
22 Jun 2022, 17:03:06 UTC
Previous filing
21 Mar 2022
Next filing
21 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Sale $20,323 -1,145 -0.39% $17.75 290,086 17 Jun 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units ("RSUs") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.
F2 Includes 937 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022.
F3 Includes 46,688 RSUs.

Remarks:

President, Research and Development